BioInvest
@bioinvest.com
For more than 30 years, the MTSL (Medical Technology Stock Letter), published by BioInvest, has provided independent investment advice based on rigorous analysis of emerging biotechnology companies and a unique perspective on industry fundamentals. MTSL has a proven track record of identifying many of today’s industry leaders well before the consensus of other analysts.
BioInvest's Company Logos
BioInvest's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#A9B8C3
Cadet Blue
169, 184, 195
205, 18, 71
13, 6, 0, 24
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000066
Navy Blue
0, 0, 102
240, 100, 20
100, 100, 0, 60
About BioInvest
BioInvest, a renowned brand in the investment industry, has been providing independent investment advice for over 30 years through its flagship publication, the Medical Technology Stock Letter (MTSL). Leveraging rigorous analysis, BioInvest offers valuable insights into emerging biotechnology companies, helping investors make informed decisions. With a unique perspective on industry fundamentals, MTSL has a proven track record of identifying industry leaders well ahead of other analysts.
BioInvest's comprehensive portfolio includes various promising companies such as Acadia, Alkermes, BioMarin, and Incyte, among others. Their recommended portfolio delivers updates and news on these companies, keeping investors up-to-date with the latest developments. BioInvest's dedication to research and analysis is evident in their whitepapers, which cover topics like neurology focus, cardiovascular outcomes trials, and mast cell diseases.
As an established brand, BioInvest is committed to providing reliable investment advice and ensuring the success of their clients in the biotechnology sector. Visit their website to learn more about their publications and explore the dynamic world of biotech investments
Brand industry
Finance
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
